Alternatives to Ipilimumab

Developing a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Developing engineered biologics to harness the immune system for disease treatment.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Preclinical biopharma developing next-gen cancer immunotherapies using proprietary SolidT technology.

Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes.

Biotechnology company developing novel immunotherapies for cancer.

Reinventing cancer imaging and treatment through upright patient positioning.

Developing novel diagnostics to predict patient response to immunotherapy.

Immunotherapy company targeting oncology and autoimmune diseases.

Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.

Clinical-stage immunotherapy company developing novel treatments for cancer.

Clinical-stage biotech developing AI-driven metabolic immunotherapies for cancer and autoimmune diseases.

South Korean biopharmaceutical company developing novel biologics for cancer and rare diseases.

A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Mabylon is a biotechnology company focused on developing innovative antibody-based therapies for infectious diseases and cancer.

Develops and commercializes a novel cancer treatment technology called Alpha DaRT.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

A global oncology company developing and commercializing innovative cancer treatments.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

AI-powered spatial biology platform for precision medicine and drug development.

AI-driven drug discovery platform accelerating breakthrough scientific research.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

AI-driven diagnostics company predicting cancer treatment response from pathology slides.

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Develops antibody-drug conjugates (ADCs) for targeted cancer therapy.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Developing novel immunotherapies and diagnostics for cancer.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Belong.Life creates social and professional networks for patients and healthcare professionals to manage and navigate various diseases and patient journeys.

Microbiome drug discovery company developing customized phage therapies for chronic diseases.

Develops bacteria-based immunotherapy to enhance anti-tumor immunity for cancer treatment.

AI-powered, radiation-free breast cancer screening using thermal imaging.

Develops an AI-driven surgical navigation platform using 3D ultrasound for enhanced cancer treatment.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

AI-powered cancer detection and therapy solutions for early diagnosis and personalized risk assessment.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

AI-powered blood test for early cancer detection and subtyping.

Biotech company developing next-generation gene writing tools for advanced therapies.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

AI-driven clinical-grade breast cancer guide for women navigating their journey.

A global contract research organization specializing in preclinical and translational oncology research.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.